← Back to Screener
YD Bio Limited Ordinary Shares (YDES)
Price$5.31
Favorite Metrics
Price vs S&P 500 (26W)-77.50%
Price vs S&P 500 (4W)-9.86%
Market Capitalization$382.42M
All Metrics
Book Value / Share (Quarterly)$0.07
P/TBV (Annual)9.30x
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-59.51%
EPS (TTM)$-1.03
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$-1.03
EPS (Annual)$-0.02
ROI (Annual)-21.30%
Gross Margin (Annual)30.44%
Cash / Share (Quarterly)$0.01
ROA (Last FY)-20.56%
EBITD / Share (TTM)$-0.14
Cash Flow / Share (Annual)$-0.07
P/B Ratio75.16x
P/B Ratio (Quarterly)8.39x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)10.54x
ROA (TTM)-123.83%
EPS Incl Extra (Annual)$-0.02
Current Ratio (Annual)13.18x
Quick Ratio (Quarterly)1.16x
3-Month Avg Trading Volume0.04M
Tangible BV / Share (Quarterly)$0.03
P/S Ratio (Annual)749.32x
Asset Turnover (Annual)0.07x
52-Week High$31.00
EPS Excl Extra (Annual)$-0.02
26-Week Price Return-68.75%
Quick Ratio (Annual)12.93x
13-Week Price Return-53.90%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)1.86x
Enterprise Value$382.48
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-271.67%
Cash / Share (Annual)$0.04
3-Month Return Std Dev98.77%
Net Income / Employee (TTM)$-1
ROE (Last FY)-21.42%
EPS Basic Excl Extra (Annual)$-0.02
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-1.03
Revenue / Share (Annual)$0.01
Tangible BV / Share (Annual)$0.06
Year-to-Date Return-55.37%
5-Day Price Return-5.23%
EPS Normalized (Annual)$-0.02
Net Profit Margin (Annual)-276.58%
Month-to-Date Return-29.35%
EBITD / Share (Annual)$-0.02
Operating Margin (Annual)-286.45%
LT Debt / Equity (Annual)0.00x
EPS Basic Excl Extra (TTM)$-1.03
P/TBV (Quarterly)19.53x
P/B Ratio (Annual)5.52x
Book Value / Share (Annual)$0.09
Price vs S&P 500 (13W)-56.76%
Beta-0.07x
52-Week Low$5.12
Industry Peers — Health Services(21)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
YDESYD Bio Limited Ordinary Shares | — | — | — | — | $5.31 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $207.74 |
LHLabcorp Holdings Inc. | 25.31x | 7.25% | 9.92% | 10.28% | $269.19 |
DGXQuest Diagnostics Inc. | 21.75x | 11.78% | 14.10% | 13.88% | $196.31 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $91.07 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $57.85 |
VCYTVeracyte, Inc. | 39.66x | 16.01% | 11.17% | 5.33% | $33.45 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $51.20 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $21.29 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.44 |
About
YD Bio Ltd develops blood-based cancer detection technologies and stem cell and exosome-based therapeutics targeting high unmet medical needs in tissue regeneration and immune disorders. The company also supplies clinical testing drugs for pharmaceutical partners. Its platform addresses degenerative diseases and offers potential applications in personalized medicine.